Ultra-Long Peripheral Catheter Versus Accelerated Seldinger Technique Long Peripheral Catheter in Difficult IV Access Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Ghent

About this trial

The aim of this study is to perform a comparative analysis of clinical outcomes associated with the use of an ultra-long peripheral catheter using (catheter-over-the-needle technique) versus an AST-long peripheral catheter in adult patients with difficult intravenous access (DIVA) in a real-world clinical setting. Specifically, the study will assess potential benefits, including longer mean catheter dwell time and improved catheter usability, as well as potential harms, such as increased incidence of catheter-related thrombosis, infections, phlebitis, infiltration, and unplanned catheter removal.

Eligibility criteria

Qualifiers

Adult inpatients with DIVA, requiring placement of a long peripheral catheter, will be included in the study.

A digital request form for venous access must be completed by the treating physician at the ward.

Patients must be proficient in either Dutch or French

Patients must have decision-making capacity or be represented by a legal representative.

Disqualifiers

Expected therapy duration of less than 24 hours

pregnancy

Need for central venous access

Inability to locate a deep peripheral vein in the upper extremity prior enrollment in the study

Trial design

Treatments tested in this trial

  • Powerglide pro™
  • Introcan safety deep access

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators